In order to better understand the mechanisms by which Clobetasol- and Tacrolimus-mediated signaling repress psoriasis in our model, we examined the mRNA expression of IL-17a and IL-17f that are known potent cytokines in psoriatic plaques [14]. This evidence concerns the gene IL17A and psoriasis.